Interestingly, the activation of this pathway is persistent because the O-GlcNAcylation of c-Jun is capable of increasing AGER expression, thus forming a positive feedback loop, suggesting that targeting AGER may be a promising approach for HCC [14]. The gene discussed is AGER; the disease is hepatocellular carcinoma.